Apollo Hospitals' standalone revenues up 19%
Q3FY15 Standalone Revenues were Rs. 11,825 million compared to Rs. 9,933 million in Q3FY14,up by 19%. EBITDA was higher by 11% from Rs. 1,578 million in Q3FY14 to Rs. 1,747 million inQ3FY15.
The EBITDA margin was at 14.8%, including the initial operating losses on new facilities launched recently. PAT grew by 14% to Rs. 950 million in Q3FY15.
Standalone Revenues for 9MFY15 were Rs. 33,891 million compared to Rs. 28,634 million for9MFY14, growing by 18%. EBITDA grew by 8.6% at Rs. 5,036 million for 9MFY15 from Rs. 4,638 million for 9MFY14.
Profit after Tax (PAT) improved by 8% from Rs. 2,494 million for 9MFY14 to Rs. 2,693 million for 9MFY15.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
